Showing results (31-40 of 463) with videos related to
Sort By:
Pageof 47
Journal of Clinical Immunology|July 1, 1997
The growth arresting effect of human immunoglobulin for intravenous use is mediated by antibodies recognizing membrane glycolipidsW M Vuist, I N Van Schaik, M Van Lint, et al.Dermatology (Basel, Switzerland)|December 28, 2006
C-kit Asp-816-Val mutation analysis in patients with mastocytosisA Verzijl, R Heide, A P Oranje, et al.Journal of Neuroimmunology|October 1, 1994
Anti-GM1 antibodies in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg)I N van Schaik, M Vermeulen, P A van Doorn, et al.Current Pain and Headache Reports|September 3, 2013
Fabry disease: a rare cause of neuropathic painMarieke Biegstraaten, Gabor E Linthorst, Ivo N van Schaik, et al.The Netherlands Journal of Medicine|May 29, 2013
A clinical approach to pharmacogeneticsL C G de Graaff, R H N van Schaik, T van GelderFrontiers in Pharmacology|October 12, 2020
Pharmacogenetics in Psychiatry: An Update on Clinical UsabilityRon H N van Schaik, Daniel J Müller, Alessandro Serretti, et al.Clinical Chemistry|October 18, 2008
Clinical impact of new prostate-specific antigen WHO standardization on biopsy rates and cancer detectionF H Jansen, M Roobol, C H Bangma, et al.Molecular Diagnosis & Therapy|November 30, 2012
Pharmacogenetics in kidney transplantation: recent updates and potential clinical applicationsLaure Elens, Dennis A Hesselink, Ron H N van Schaik, et al.Pharmacogenomics|June 4, 2008
A drug transporter for all ages? ABCB1 and the developmental pharmacogenetics of cyclosporineDennis A Hesselink, Ron H N van Schaik, Jeroen Nauta, et al.Clinical Chemistry|June 23, 2017
Analgesia and Opioids: A Pharmacogenetics Shortlist for Implementation in Clinical PracticeMaja Matic, Saskia N de Wildt, Dick Tibboel, et al.Pageof 47